With the purchase of a former Lonza biologics plant now in the books, San Francisco-based CDMO Joinn Biologics is expanding from one Bay Area to another. Over the weekend, Joinn announced (Chinese) that it has completed its acquisition of Lonza’s 183,000-square-foot manufacturing facility in Guangzhou, China. Joinn expects the move to help it build out its presence in China’s Greater Bay Area, comprising Guangdong province (where the capital city of Guangzhou is located), Hong Kong and Macau. The transaction follows Lonza’s decision to shutter the facility—which it bought from GE HealthCare in 2018 and opened in 2021—last January.
Read the full article: CDMO Joinn Biologics Snaps up China Biologics Plant from Lonza in Push to Tackle Asia-Pacific Market //
Source: https://www.fiercepharma.com/pharma/cdmo-joinn-biologics-snaps-china-biologics-plant-lonza-push-tackle-asia-pacific-market